SELLAS Life Sciences Group(DE:RXK3)
€7.46-0.04 (-0.53%)
DE:RXK3
SELLAS Life Sciences Group earnings date
€7.46
At close:-0.04 (-0.53%)
SELLAS Life Sciences Group (RXK3) Q2 2020 Earnings Report
2 Followers
DE:RXK3 Q2 2020 EPS Results
- Actual EPS
- -EUR 0.60
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 5.90
DE:RXK3 Q2 2020 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 08/13/2020
- Time
- After Close
- Conference Call
- Thursday, August 13, 2020
DE:RXK3 Upcoming Earnings
SELLAS Life Sciences Group's next earnings date is estimated for March 25, 2027, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:RXK3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 25, 2027 | 2026 (Q4) | -0.05- | -0.05 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.05-0.05 | -0.05 | 16.67% (+0.01) | |
| Aug 11, 2026 | 2026 (Q2) | -0.04-0.05 | -0.06 | 28.57% (+0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.05-0.05 | -0.06 | 28.57% (+0.02) | |
| Mar 19, 2026 | 2025 (Q4) | -0.06-0.05 | -0.05 | 16.67% (+0.01) | |
| Nov 12, 2025 | 2025 (Q3) | -0.07-0.05 | -0.09 | 40.00% (+0.04) | |
| Aug 12, 2025 | 2025 (Q2) | -0.07-0.06 | -0.12 | 46.15% (+0.05) | |
| May 13, 2025 | 2025 (Q1) | -0.10-0.06 | -0.19 | 66.67% (+0.13) | |
| Mar 20, 2025 | 2024 (Q4) | -0.10-0.05 | -0.21 | 73.91% (+0.15) | |
| Nov 13, 2024 | 2024 (Q3) | -0.12-0.09 | -0.3 | 69.70% (+0.21) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
